Hanmi Pharm. Co., Ltd.
128940
Kedudukan dalam Saham
#4356
A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was... A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was established in Seoul, South Korea, in 1973. The firm concentrates its efforts on researching and developing medical therapies for a range of health issues, including diabetes, obesity, cancer, autoimmune disorders, and various rare diseases.
Harga Saham
$279.16
Modal Pasaran
$3.54B
Perubahan (1 hari)
-2.37%
Perubahan (1 tahun)
14.50%
Negara
KR
Perdagangan Hanmi Pharm. Co., Ltd. (128940)
Kategori
Healthcare
Nisbah P/B bagi Hanmi Pharm. Co., Ltd. (128940)
Nisbah P/B pada October 2026 TTM: 3.41
Menurut laporan kewangan dan harga saham terkini Hanmi Pharm. Co., Ltd., nisbah P/B semasa (TTM) ialah 3.41. Pada akhir 2024, nisbah P/B syarikat ialah 3.28.
Sejarah nisbah P/B untuk Hanmi Pharm. Co., Ltd. dari 2010 hingga 2026
Nisbah P/B pada akhir setiap tahun
| Tahun | Nisbah P/B | Ubah |
|---|---|---|
| 2026 (TTM) | 3.41 | -26.30% |
| 2025 | 4.63 | 41.29% |
| 2024 | 3.28 | -31.05% |
| 2023 | 4.76 | 11.71% |
| 2022 | 4.26 | 1.30% |
| 2021 | 4.20 | -30.24% |
| 2020 | 6.02 | 22.45% |
| 2019 | 4.92 | -32.09% |
| 2018 | 7.24 | -19.42% |
| 2017 | 8.99 | 104.30% |
| 2016 | 4.40 | -60.04% |
| 2015 | 11.01 | 461.75% |
| 2014 | 1.96 | -20.03% |
| 2013 | 2.45 | -9.44% |
| 2012 | 2.71 | 88.62% |
| 2011 | 1.44 | -32.67% |
| 2010 | 2.13 | 0.00% |
Nisbah P/B untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/B | Perbezaan Nisbah P/B | Negara |
|---|---|---|---|
| 1.9834 | -41.88% |
DE
|
|
| 2.1139 | -38.05% |
DE
|
|
| 1.3124 | -61.54% |
JP
|
|
| 6.3468 | 85.99% |
CH
|
|
| 5.0287 | 47.36% |
IN
|
